521 related articles for article (PubMed ID: 29727835)
21. Controlling the burst release of amorphous drug-polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains.
Nguyen MH; Tran TT; Hadinoto K
Eur J Pharm Biopharm; 2016 Jul; 104():156-63. PubMed ID: 27179586
[TBL] [Abstract][Full Text] [Related]
22. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility.
Cheow WS; Hadinoto K
J Colloid Interface Sci; 2012 Feb; 367(1):518-26. PubMed ID: 22051687
[TBL] [Abstract][Full Text] [Related]
23. Green amorphous nanoplex as a new supersaturating drug delivery system.
Cheow WS; Hadinoto K
Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
[TBL] [Abstract][Full Text] [Related]
24. Amorphization strategy affects the stability and supersaturation profile of amorphous drug nanoparticles.
Cheow WS; Kiew TY; Yang Y; Hadinoto K
Mol Pharm; 2014 May; 11(5):1611-20. PubMed ID: 24669821
[TBL] [Abstract][Full Text] [Related]
25. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method.
Shin GH; Chung SK; Kim JT; Joung HJ; Park HJ
J Agric Food Chem; 2013 Nov; 61(46):11119-26. PubMed ID: 24175657
[TBL] [Abstract][Full Text] [Related]
26. Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug.
Lim LM; Park JW; Hadinoto K
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631565
[TBL] [Abstract][Full Text] [Related]
27. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of curcumin solid dispersion using HPMC.
Yu JY; Kim JA; Joung HJ; Ko JA; Park HJ
J Food Sci; 2020 Nov; 85(11):3866-3873. PubMed ID: 33067846
[TBL] [Abstract][Full Text] [Related]
29. Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing.
Karri VV; Kuppusamy G; Talluri SV; Mannemala SS; Kollipara R; Wadhwani AD; Mulukutla S; Raju KR; Malayandi R
Int J Biol Macromol; 2016 Dec; 93(Pt B):1519-1529. PubMed ID: 27180291
[TBL] [Abstract][Full Text] [Related]
30. Proof-of-concept preparation and characterization of dual-drug amorphous nanoparticle complex as fixed-dose combination of poorly soluble drugs.
Yu H; Ming Lim L; Dong B; Hadinoto K
Drug Dev Ind Pharm; 2019 Jan; 45(1):105-116. PubMed ID: 30196726
[TBL] [Abstract][Full Text] [Related]
31. Morphological and Physicochemical Evaluation of Two Distinct Glibenclamide/Hypromellose Amorphous Nanoparticles Prepared by the Antisolvent Method.
Yonashiro H; Higashi K; Morikawa C; Ueda K; Itoh T; Ito M; Masu H; Noguchi S; Moribe K
Mol Pharm; 2018 Apr; 15(4):1587-1597. PubMed ID: 29502422
[TBL] [Abstract][Full Text] [Related]
32. Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity.
Popat A; Karmakar S; Jambhrunkar S; Xu C; Yu C
Colloids Surf B Biointerfaces; 2014 May; 117():520-7. PubMed ID: 24698148
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and cytotoxicity of folate-modified curcumin-loaded PLA-PEG micellar nano systems with various PLA:PEG ratios.
Phan QT; Le MH; Le TT; Tran TH; Xuan PN; Ha PT
Int J Pharm; 2016 Jun; 507(1-2):32-40. PubMed ID: 27150945
[TBL] [Abstract][Full Text] [Related]
34. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
35. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities.
Yen FL; Wu TH; Tzeng CW; Lin LT; Lin CC
J Agric Food Chem; 2010 Jun; 58(12):7376-82. PubMed ID: 20486686
[TBL] [Abstract][Full Text] [Related]
36. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
37. A Co-Encapsulation of Coenzyme Q10 and Curcumin in Liposomes Coated with Chitosan (Q10-Cur-Lip-Chi) with Enhanced Solubility and Stability for Good Release Performance and Antioxidative Activity.
Yu L; Chao C; Li Q; Ye S; Lin J; Zhong S; Xuan Q; Xu K; Zhao S
Curr Drug Deliv; 2023; 20(9):1391-1403. PubMed ID: 35786187
[TBL] [Abstract][Full Text] [Related]
38. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
Fan N; Lu T; Li J
J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
[TBL] [Abstract][Full Text] [Related]
39. Preserving the supersaturation generation capability of amorphous drug-polysaccharide nanoparticle complex after freeze drying.
Kiew TY; Cheow WS; Hadinoto K
Int J Pharm; 2015 Apr; 484(1-2):115-23. PubMed ID: 25724131
[TBL] [Abstract][Full Text] [Related]
40. A novel approach of encapsulating curcumin and succinylated derivative in mannosylated-chitosan nanoparticles.
Idoudi S; Hijji Y; Bedhiafi T; Korashy HM; Uddin S; Merhi M; Dermime S; Billa N
Carbohydr Polym; 2022 Dec; 297():120034. PubMed ID: 36184178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
